EA201100463A1 - Recombinant PSEUDOADENOVIRUS NANOPARTICLES, PHARMACEUTICAL COMPOSITION FOR PREVENTION OR INFLUENZA THERAPY (OPTIONS), METHOD OF PREVENTION OR INFLUENZA THERAPY - Google Patents
Recombinant PSEUDOADENOVIRUS NANOPARTICLES, PHARMACEUTICAL COMPOSITION FOR PREVENTION OR INFLUENZA THERAPY (OPTIONS), METHOD OF PREVENTION OR INFLUENZA THERAPYInfo
- Publication number
- EA201100463A1 EA201100463A1 EA201100463A EA201100463A EA201100463A1 EA 201100463 A1 EA201100463 A1 EA 201100463A1 EA 201100463 A EA201100463 A EA 201100463A EA 201100463 A EA201100463 A EA 201100463A EA 201100463 A1 EA201100463 A1 EA 201100463A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prevention
- influenza
- nanoparticles
- recombinant
- influenza therapy
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к рекомбинантной псевдоаденовирусной наночастице, несущей экспрессирующую кассету, содержащую нуклеотидную последовательность, которая кодирует однодоменное мини-антитело, связывающееся с вирусом гриппа, и применимой для профилактики и терапии гриппа. Предусмотрены фармацевтические композиции как содержащие только указанные псевдоаденовирусные наночастицы, так и содержащие дополнительно кодируемые ими однодоменные мини-антитела против вируса гриппа, например, относящегося к типу А (и характеризующегося антигенными формулами H1N(1-9), H3N(1-9) или H5N(1-9)) или к типу В. Композиции предпочтительно вводят интраназально.The invention relates to a recombinant pseudoadenoviral nanoparticle carrying an expression cassette containing a nucleotide sequence that encodes a single-domain mini-antibody that binds to the influenza virus, and is applicable for the prevention and treatment of influenza. Pharmaceutical compositions are provided both containing only the indicated pseudoadenoviral nanoparticles and containing additionally encoded single-domain mini-antibodies against the influenza virus, for example, belonging to type A (and characterized by the antigenic formulas H1N (1-9), H3N (1-9) or H5N (1-9)) or to type B. The compositions are preferably administered intranasally.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201100463A EA201100463A1 (en) | 2011-04-05 | 2011-04-05 | Recombinant PSEUDOADENOVIRUS NANOPARTICLES, PHARMACEUTICAL COMPOSITION FOR PREVENTION OR INFLUENZA THERAPY (OPTIONS), METHOD OF PREVENTION OR INFLUENZA THERAPY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201100463A EA201100463A1 (en) | 2011-04-05 | 2011-04-05 | Recombinant PSEUDOADENOVIRUS NANOPARTICLES, PHARMACEUTICAL COMPOSITION FOR PREVENTION OR INFLUENZA THERAPY (OPTIONS), METHOD OF PREVENTION OR INFLUENZA THERAPY |
Publications (2)
Publication Number | Publication Date |
---|---|
EA016517B1 EA016517B1 (en) | 2012-05-30 |
EA201100463A1 true EA201100463A1 (en) | 2012-05-30 |
Family
ID=46163584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201100463A EA201100463A1 (en) | 2011-04-05 | 2011-04-05 | Recombinant PSEUDOADENOVIRUS NANOPARTICLES, PHARMACEUTICAL COMPOSITION FOR PREVENTION OR INFLUENZA THERAPY (OPTIONS), METHOD OF PREVENTION OR INFLUENZA THERAPY |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201100463A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2560699C2 (en) * | 2013-08-02 | 2015-08-20 | федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский ядерный университет МИФИ" (НИЯУ МИФИ) | Method of creating nanosized diagnostic label based on conjugates of nanoparticles and single domain antibodies |
MX2019000925A (en) * | 2016-07-19 | 2019-06-03 | Ibentrus Inc | Bispecific proteins and methods for preparing same. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745107B (en) * | 2008-12-10 | 2012-06-06 | 中国农业科学院哈尔滨兽医研究所 | Recombinant replication-defective adenoviral vector H5N1 subtype influenza genetic engineering vaccine |
-
2011
- 2011-04-05 EA EA201100463A patent/EA201100463A1/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
EA016517B1 (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201491548A1 (en) | 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT | |
CY1116987T1 (en) | Concentrated imidazolylimidazoles as antiviral compounds | |
EA201391561A1 (en) | NEW CONNECTIONS-MODULATORS GPR-119 | |
MX2015012397A (en) | Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy. | |
UA109991C2 (en) | CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION | |
EA201490377A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE | |
EA201790781A3 (en) | ANTI-VIRUS COMPOUNDS | |
UA111841C2 (en) | BENZOTHIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATION | |
EA201491362A1 (en) | ANESTHYZING COMPOUNDS AND METHODS OF THEIR APPLICATION | |
EA201590358A1 (en) | Inhibitors of Human Immunodeficiency Virus Replication | |
EA201400591A1 (en) | INHALER | |
EA201490588A1 (en) | METHODS OF TREATMENT OF HEPATITIS C VIRUS | |
EA201590343A1 (en) | ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES | |
MY182771A (en) | Viral replication inhibitors | |
MD4602B1 (en) | Inhibitors of hepatitis C virus | |
JO3438B1 (en) | Aryl- or heteroaryl-substituted benzene compounds | |
EA201490254A1 (en) | COMBINED TREATMENT OF HEPATITIS C | |
EA201590667A1 (en) | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
PH12015502230B1 (en) | Novel viral replication inhibitors | |
EA201391515A1 (en) | INACTIVATED DENGE VIRUS VACCINE | |
TN2014000112A1 (en) | Ep1 receptor ligands | |
JO3281B1 (en) | Benzofuran Compounds for the Treatment of Hepatitis C Virus Infections | |
EA201491500A1 (en) | FIBROZA TREATMENT METHODS | |
EA201590364A1 (en) | APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD | |
EA201590460A1 (en) | METHOD AND MEANS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY (+) RNA-CONTAINING VIRUSES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC4A | Change in name of a patent proprietor in a eurasian patent | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): MD |
|
TC4A | Change in name of a patent proprietor in a eurasian patent | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
NF4A | Restoration of lapsed right to a eurasian patent |
Designated state(s): AM AZ BY KZ KG TJ TM |